's Avatar

@aga-gihn.bsky.social

176 Followers  |  122 Following  |  116 Posts  |  Joined: 26.11.2024  |  1.5928

Latest posts by aga-gihn.bsky.social on Bluesky

Novel Anti-TL1a Antibody Shows Potential for Crohn’s Disease | MDedge Duvakitug, a novel anti-TL1a monoclonal antibody, demonstrated statistically significant differences in endoscopic response rates compared to placebo in adults

Duvakitug, a novel anti-TL1a antibody, showed potential for adults with Crohn's disease, a study presented at #ACG2025 found. Learn more πŸ‘‰

24.11.2025 15:03 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Post image

Pediatric Wilson’s disease πŸ”—linked to higher risk and worse outcomes compared with adults, according to a new study in @aga-ghadvances.bsky.social: ow.ly/lH9050XrUzs

20.11.2025 15:02 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Post image

β€œPatients often raise questions about colonics or detox teas, especially when these gain traction on social media platforms like TikTok." β€” Tauseef Ali, MD, AGAF

How should GIs approach this conversation about colon cleanses? We spoke to @bilalmohammadmd.bsky.social and more: ow.ly/Vsih50XnUNu

17.11.2025 16:03 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Preview
AI in Gastroenterology and Endoscopy | MDedge In this issue of Perspectives, we present two timely essays that explore how AI is reshaping clinical careβ€”while also emphasizing the need for caution, thoughtf

In this month's Perspectives column, we explore how AI is reshaping clinical care β€” while also emphasizing the need for caution, thoughtful integration, and ongoing oversight.

14.11.2025 13:01 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Post image

Dr. Manol Jovani is our November member spotlight! In an interview, Dr. Jovani discusses third space endoscopy, his advice for aspiring med students, and where he sees the #GI field going in the next 5 years.

πŸ‘‰https://ow.ly/6G7n50Xnfbk

11.11.2025 15:03 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Post image

This study published in @AmJGastro found that cold snare usage for removing small polyps was lower than expected for U.S. endoscopists, despite being the recommended method. ow.ly/7bH550XnVlM

07.11.2025 13:02 β€” πŸ‘ 0    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Post image

Our November issue is live! Don't miss our articles on:
⭐Member spotlight
⭐Physician payment gains and gaps
⭐Clinical implications of the new liver nomenclature
⭐Perspectives on AI in #GI and endoscopy

Read now: ow.ly/ErcI50Xnf0g

05.11.2025 18:00 β€” πŸ‘ 1    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Post image

The @fda.gov expands Rinvoq's use for #IBD: Now approved for adults with moderate-to-severe #UC or Crohn’s who’ve tried β‰₯1 systemic therapy β€” no need to fail a TNF blocker first. www.mdedge.com/gihepnews/ar...

31.10.2025 16:05 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Preview
Half of Patients Skip Repeat Stool Tests for CRC Screening | MDedge fewer than half of adults who startedΒ colorectal cancerΒ (CRC) screening with an at-home stool test completed the recommended repeat test, creating gaps in prote

πŸ†• study in BMJ Public Health finds less than half of adults who start #CRC screening with an at-home stool test completed the recommended repeat test, But β€œthe best CRC screening test is the one that gets done,” said author Dr. Staci J. Wendt.

29.10.2025 15:07 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Anti-TNF Exposure Influences Efficacy of Subsequent Therapies in UC | MDedge Prior exposure to tumor necrosis factor (TNF) antagonists may weaken the benefit of some advanced therapies for ulcerative colitis (UC) while enhancing the effi

From @aga-cgh.bsky.social: anti-TNF antagonists may weaken the benefit of some advanced therapies for #UC, while enhancing the efficacy of others.

27.10.2025 14:06 β€” πŸ‘ 0    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Post image

From #UEGWeek: Dr. Maria Effenberg highlighted clinical implications of the new liver disease nomenclature and discussed pros and cons. @myueg.bsky.social ow.ly/wb9Q50XbQNx

23.10.2025 13:04 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Preview
Is AI Use Causing Endoscopists to Lose Their Skills? | MDedge Routine use of artificial intelligence (AI) may lead to a loss of skills among clinicians who perform colonoscopies, thereby affecting patient outcomes

Is #AI causing endoscopists to lose their skills? We spoke to lead authors from the study published in @lancetgastrohep.bsky.social.

➑️

22.10.2025 12:06 β€” πŸ‘ 1    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Post image

Our October member spotlight is Dr. Pascale M. White! Dr. White discusses her mission to connect with communities to improve screening rates for colorectal cancer, her position as co-founder of ABGH, and more in our interview: ow.ly/Ay8N50XbRwb

21.10.2025 17:00 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Post image

πŸŽƒ Have you read our October issue yet? This month, we summarize global guidelines for pregnancy and #IBD, provide an update on the FDA approval of semaglutide for MASH with fibrosis, and highlight member spotlight Dr. Pascale M. White.

πŸ“° Read now: ow.ly/UxnR50XbQxv

15.10.2025 15:50 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Post image

In this video from The New Gastroenterologist and DHPA, Dr. Peter Naas shares advice for young GIs starting a career in private practice gastroenterology. πŸŽ₯ Watch now: ow.ly/NSlx50WNKMj

01.10.2025 12:56 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Post image

To be an effective #GI consultant, Dr. Allon Kahn advises being the following 5️⃣ things: kind, timely, specific, helpful and honest.

Read more of his tips for The New Gastroenterologist: ow.ly/eEPa50WNKKV

25.09.2025 14:03 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Post image

More than 10% of GIs may face a malpractice claim, but it’s rarely discussed in med school. For The New Gastroenterologist, Dr. Koushik Das explains what malpractice is, the timeline of a lawsuit, and other consequences you might need to know. πŸ‘‰ ow.ly/YaO950WNKJh

22.09.2025 13:06 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Post image

In this month's Perspectives column, Dr. Anahita Rabiee and Dr. Tarek Sawa discuss approaches to esophageal varices and Barrett’s esophagus, highlighting shifts in screening, surveillance, & innovation in GI care.

πŸ”— Read more: ow.ly/gMiq50WRtGz

19.09.2025 12:03 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Post image

#GLP1 has become a cornerstone in diabetes in weight loss management. For The New Gastroenterologist, Dr. Nikiya Asamoah & Dr. Sitharthan Sekar review current evidence and guidelines for GLP-1 use for endoscopic procedures ➑️ ow.ly/nZet50WNKHC

17.09.2025 20:02 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Post image

Exocrine pancreatic insufficiency is a challenging diagnosis. In this month’s In Focus, review how to approach diagnosing and treating EPI, plus screening for complications. www.mdedge.com/gihepnews/ar...

16.09.2025 16:04 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Post image

The latest issue of The New Gastroenterologist is live! In this issue, we cover exocrine pancreatic insufficiency, GLP-1 use, medical malpractice lawsuits and more. ow.ly/40bJ50WNKEQ

11.09.2025 14:05 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Post image

πŸ–€ Ready to be inspired and uplifted? #ABGHNexus2025 is bringing together Black women in medicine for an unforgettable experience Oct. 3–5 at The Times Center, NYC! Join ABGH for connection, growth, and empowermentβ€”register by Sept. 19 to save! #BlackWomenInMedicine whova.com/portal/regis...

10.09.2025 21:54 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Post image

Our September member spotlight is @jessicakormanmd.bsky.social, whose mission is to reduce the stigma around anal cancer.

β€œI think GIs are uniquely positioned to help with diagnosing anal diseases. It is part of the digestive tract." Read ➑️ ow.ly/GGlw50WQCqc

10.09.2025 13:03 β€” πŸ‘ 0    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Post image

New #IBS in America survey reveals that IBS symptoms continue to disrupt lives β€” an average of 19 days each month. ow.ly/5Ij650WOeEK

08.09.2025 12:56 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Wegovy Approved for MASH With Fibrosis, No Cirrhosis | MDedge The FDA has grantedΒ accelerated approvalΒ to Novo Nordisk’s Wegovy for the treatment of metabolic-associated steatohepatitis (MASH) in adults with moderate-to-ad

The @fda.gov has approved @novonordisk.bsky.social's Wegovy for treating MASH in adults with fibrosis but without cirrhosis. Learn more: www.mdedge.com/gihepnews/ar...

05.09.2025 15:03 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Post image

A new @aga-gastro.bsky.social clinical practice update, published in @aga-cgh.bsky.social, offers guidance for identifying GI symptoms in patients with hypermobile Ehlers-Danlos syndrome. ➑️ ow.ly/NsGz50WNKtq

04.09.2025 14:03 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Post image

Happy September! ✏️🍎 Be sure to check out this month's new issue, including:
βœ”οΈMember spotlight on Dr. Jessica Korman
βœ”οΈ5 tips on becoming a GI consultant by
βœ”οΈColonoscopy screening effective in 45- to 49-year-olds

Read more: ow.ly/LJeT50WPzkH

03.09.2025 16:00 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Follow-Up Colonoscopies Low After Blood-Based Screening | MDedge People receiving blood-based colorectal screening tests showed disappointingly low rates of receiving follow-up colonoscopies that are essential when tests are

Follow-up colonoscopies are low after blood-based CRC screening, raising concerns about missed diagnoses. New research led by Dr. Timothy Zaki in @aga-gastro.bsky.social highlights the need for better patient education and system-level interventions. ➑️

22.08.2025 14:03 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
IBD Medications Show No Link with Breast Cancer Recurrence | MDedge Medications for inflammatory bowel disease (IBD) appear to have no impact on risk of incident malignancies among patients with a history of breast cancer

πŸš«πŸ”— New study in @aga-cgh.bsky.social shows no association between IBD medications and breast cancer recurrence, even among patients receiving anti-TNF agents or immunomodulators.

Dr. Mahadevan weighs in on the clinical implications. Read more:

20.08.2025 13:04 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Preview
Alarming Rise in Early-Onset GI Cancers Calls for Early Screening, Lifestyle Change | MDedge Early-onset gastrointestinal (GI) cancers diagnosed before age 50 are rising at alarming rates worldwide, underscoring the need for enhanced prevention strategi

New review from @jama.com: Early onset #GI cancers are rising worldwide, calling for enhanced prevention strategies. Read more about what challenges this creates for treatment and the importance of early detection: πŸ”—

18.08.2025 12:04 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0

@aga-gihn is following 20 prominent accounts